Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ulrich Bothe is active.

Publication


Featured researches published by Ulrich Bothe.


Bioorganic & Medicinal Chemistry Letters | 2018

Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis

Imadul Islam; Shendong Yuan; Christopher West; Marc Adler; Ulrich Bothe; Judi Bryant; Zheng Chang; Kieu Chu; Kumar Emayan; Giovanna Gualtieri; Elena Ho; David Light; Cornell Mallari; John Morser; Gary Phillips; Caralee Schaefer; Drew Sukovich; Marc Whitlow; Deborah Chen; Brad O. Buckman

We report here the design and synthesis of a novel series of benzylamines that are potent and selective inhibitors of uPA with promising oral availability in rat. Further evaluation of one representative (ZK824859) of the new structural class showed that this compound lowered clinical scores when dosed in either acute or chronic mouse EAE models, suggesting that uPA inhibitors of this type could be useful for the treatment of multiple sclerosis.


Archive | 2006

Fluorenes and carbazoles as ligands of the ep2 receptor

Nico Bräuer; Bernd Buchmann; Christoph Huwe; Bernhard Lindenthal; Gernot Langer; Olaf Peters; Gerd Schubert; Ulrich Bothe; Luisella Toschi; Michaele Peters-Kottig


Archive | 2008

Alkynylpyrimidines as tie2 kinase inhibitors

Ingo Hartung; Ulrich Bothe; Georg Kettschau; Ulrich Luecking; Anne Mengel; Martin Krueger; Karl-Heinz Thierauch; Philip Lienau; Ulf Boemer


Archive | 2004

2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action

Alexander Hillisch; Olaf Peters; Christian Gege; Wilko Regenhardt; Dirk Kosemund; Gerhard Siemeister; Eberhard Unger; Ulrich Bothe


Archive | 2006

Benzofuranone derivatives as nonsteroidal progesterone receptor modulators

Wolfgang Schwede; Carsten Moeller; Anja Schmidt; Ulrike Fuhrmann; Norbert Schmees; Ulrich Bothe


Archive | 2011

6,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicaments

Tim Wintermantel; Carsten Möller; Ulrich Bothe; Reinhard Nubbemeyer; Ludwig Zorn; Dirk Kosemund; Laak Antonius Ter; Rolf Bohlmann; Lars Wortmann; Donald Bierer


Archive | 2008

ALKYNYLPYRIMIDINES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, METHODS OF PREPARING SAME AND USES OF SAME

Ingo Hartung; Ulrich Bothe; Georg Kettschau; Ulrich Luecking; Anne Mengel; Martin Krueger; Karl Heinz Thierauch; Philip Lienau; Ulf Boemer


Archive | 2016

Combinations of inhibitors of irak4 with inhibitors of btk

Ulrich Bothe; Antje Margret Wengner; Holger Siebeneicher; Nicole Schmidt; Reinhard Nubbemeyer; Ulf Bömer; Judith Günther; Holger Steuber; Martin Lange; Christian Stegmann; Andreas Sutter; Roland Neuhaus


Archive | 2014

6,7-dihydro-5h-benzo[7]annulene derivatives, methods for the production thereof, pharmaceutical preparations that contain said 6,7-dihydro-5h-benzo[7]annulene derivatives, and use thereof to produce drugs

Tim Wintermantel; Carsten Moeller; Ulrich Bothe; Reinhard Nubbemeyer; Ludwig Zorn; Laak Antonius Ter; Rolf Bohlmann; Lars Wortmann


Cancer Research | 2018

Abstract 1887: Preclinical evaluation of a novel interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor in combination with PI3K inhibitor copanlisib or BTK inhibitors in ABC-DLBCL

Martin Lange; Antje Margret Wengner; Ulrich Bothe; Ulf Boemer; Reinhard Nubbemeyer; Holger Siebeneicher; Holger Steuber; Judith Guenther; Lisette Potze; Nicole Schmidt; Oliver Politz; Wolf-Dietrich Doecke; Eleni Lagkadinou; Thomas Matthias Zollner; Franz von Nussbaum; Dominik Mumberg; Andreas Steinmeyer; Michael Brands; Karl Ziegelbauer

Collaboration


Dive into the Ulrich Bothe's collaboration.

Top Co-Authors

Avatar

Nicole Schmidt

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Holger Siebeneicher

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Martin Lange

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Ulf Boemer

Bayer Schering Pharma AG

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrea Rotgeri

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Andreas Sutter

Bayer HealthCare Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge